Searchable abstracts of presentations at key conferences in endocrinology

ea0019p36 | Clinical practice/governance and case reports | SFEBES2009

Carbimazole-induced myositis: a rare but significant adverse reaction

Sagi SV , Sayeed N , Oyibo SO , Roland JM

Introduction: Carbimazole is the first drug of choice for treating thyrotoxicosis. We report a case of an Asian gentleman recently started on carbimazole for thyrotoxicosis who complained of severe generalised muscle pain and weakness.Report: A sixty-four year old gentleman was diagnosed with thyrotoxicosis (TSH <0.01 mU/l, Free T4=40 pmol/l, Free T3=14.9 pmol/l) in the month of July 08 and was started on carbimazole 40 mg daily...